Naomi Melamed-Book
Naomi Melamed-Book has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Rouvinski
Department of Microbiology and Molecular Genetics, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication - Benjamin Aroeti
Department of Biological Chemistry; The Alexander Silberman Institute of Life Sciences; The Hebrew University of Jerusalem, The Edmond J. Safra Campus – Givat Ram
1 shared publication - Daniel Sharon
Institute of Chemistry The Hebrew University of Jerusalem Jerusalem 9190401 Israel
1 shared publication - Deborah E. Shalev
Wolfson Centre for Applied Structural Biology The Hebrew University of Jerusalem Jerusalem 9190401 Israel
1 shared publication - Dina Schneidman-Duhovny
The Rachel and Selim Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel
1 shared publication - Dror Merhav
Applied Physics Department, Center for Nano-Science and Nano-Technology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
Retrograde transport of plasma membrane cholesterol associates with anti-apoptotic survival of cardiac fibroblasts: role for IL-1α and StAR/STRD1
Interleukin-1α (IL-1α) induces robust expression of StAR/STRD1 protein in post-infarction (MI) cardiac fibroblasts (CFs) (Razin et al. JMCC 2021). In endocrine cells, StAR expression facilitates mitochondrial steroid hormone biosynthesis from cellular cholesterol . In the non-steroidogenic CFs, however, StAR promotes resistance to apoptogenic stress, named stoptosis. Given that the the plasma membrane (PM) is the source of steroidogenic cholesterol, we hypothesized that internalization of PM cholesterol might also be essential for the anti-apoptotic activity of the cardiac StAR. To test this possibility, IL-1α treated rat CFs expressing StAR were examined by confocal live cell imaging of added BODIPY-cholesterol, NBD-cholesterol and CF®568-cholera toxin subunit B. The results revealed that endocytosis of sphingomyelin-sequestered pool of PM cholesterol is critical for IL-1α-induced stoptosis mediated by StAR. Irrespective of IL-1α treatment, following endocytosis the retrograde pathway of cholesterol uptake includes trafficking via the trans-Golgi network (TGN) to the endoplasmic reticulum (ER) and storage in lipid droplets (LDs). Inhibition of cholesterol endocytosis by either dynamin inhibitor Dyngo-4a, or by sphingomyelinase (SMase) treatment, led to loss of stoptosis. The use of filipin and Jasplakinolide further underscored the requirement for actin-dependent vesicular cholesterol trafficking originating from caveolae-like lipidic domains. Intriguingly, StAR induction by IL-1α is associated with a marked reduction in LDs, which are increasingly recognized as pivotal markers of cellular stress. Conversely, apoptotic signals induced by cisplatin treatment or serum deprivation generate a substantial increase of LD content and clustering in conjunction with cell death. Collectively, these findings suggest that continuous vesicular uptake of PM cholesterol is essential for the anti-apoptotic activity of cardiac StAR that may turn to be cardio-protective during the inflammatory response to infarction.
- 14 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessRetrograde transport of plasma membrane cholesterol associates with anti-apoptotic survival of cardiac fibroblasts: role for IL-1α and StAR/STRD1
Interleukin-1α (IL-1α) induces robust expression of StAR/STRD1 protein in post-infarction (MI) cardiac fibroblasts (CFs) (Razin et al. JMCC 2021). In endocrine cells, StAR expression facilitates mitochondrial steroid hormone biosynthesis from cellular cholesterol . In the non-steroidogenic CFs, however, StAR promotes resistance to apoptogenic stress, named stoptosis. Given that the the plasma membrane (PM) is the source of steroidogenic cholesterol, we hypothesized that internalization of PM cholesterol might also be essential for the anti-apoptotic activity of the cardiac StAR. To test this possibility, IL-1α treated rat CFs expressing StAR were examined by confocal live cell imaging of added BODIPY-cholesterol, NBD-cholesterol and CF®568-cholera toxin subunit B. The results revealed that endocytosis of sphingomyelin-sequestered pool of PM cholesterol is critical for IL-1α-induced stoptosis mediated by StAR. Irrespective of IL-1α treatment, following endocytosis the retrograde pathway of cholesterol uptake includes trafficking via the trans-Golgi network (TGN) to the endoplasmic reticulum (ER) and storage in lipid droplets (LDs). Inhibition of cholesterol endocytosis by either dynamin inhibitor Dyngo-4a, or by sphingomyelinase (SMase) treatment, led to loss of stoptosis. The use of filipin and Jasplakinolide further underscored the requirement for actin-dependent vesicular cholesterol trafficking originating from caveolae-like lipidic domains. Intriguingly, StAR induction by IL-1α is associated with a marked reduction in LDs, which are increasingly recognized as pivotal markers of cellular stress. Conversely, apoptotic signals induced by cisplatin treatment or serum deprivation generate a substantial increase of LD content and clustering in conjunction with cell death. Collectively, these findings suggest that continuous vesicular uptake of PM cholesterol is essential for the anti-apoptotic activity of cardiac StAR that may turn to be cardio-protective during the inflammatory response to infarction.
- Open Access
- 28 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (31) , 28326-28334
Controlling Amyloid Assembly Dynamics Using Spin Interfaces
Protein aggregation into amyloid fibrils is central to numerous diseases, yet the role of electron spin interactions during nucleation and self-assembly remains unexplored. We investigated amyloid formation of A-β(1-42) polypeptide, implicated in Alzheimer's disease, and its smaller recognition motifs on ferromagnetic substrates. We observed a strong dependence of fibril formation dynamics on the substrate's magnetization orientation using electron and fluorescence microscopy. Specifically, one magnetization orientation yielded approximately twice as many and significantly longer (up to 20-fold) fibrils compared with the opposite orientation, a preference that flipped with the opposite monomer chirality. Furthermore, ATR-FTIR detected structural variations in the fibril structure, depending on the substrate magnetization. These findings suggest that transient spin polarization of the monomers during self-assembly, potentially driven by the Chiral-Induced Spin Selectivity (CISS) effect, plays a critical role in amyloid assembly dynamics. The consistency of these effects across different molecule length scales suggests a fundamental spin-based influence on biomolecular aggregation. This insight may have implications for therapeutic strategies, including the use of spin-polarized magnetic nanoparticles to selectively modulate amyloid formation in neurodegenerative diseases and the integration of spin-selective interfaces in dialysis systems to mitigate dialysis-related amyloidosis.
- 28 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (31) , 28326-28334
Open AccessControlling Amyloid Assembly Dynamics Using Spin Interfaces
Protein aggregation into amyloid fibrils is central to numerous diseases, yet the role of electron spin interactions during nucleation and self-assembly remains unexplored. We investigated amyloid formation of A-β(1-42) polypeptide, implicated in Alzheimer's disease, and its smaller recognition motifs on ferromagnetic substrates. We observed a strong dependence of fibril formation dynamics on the substrate's magnetization orientation using electron and fluorescence microscopy. Specifically, one magnetization orientation yielded approximately twice as many and significantly longer (up to 20-fold) fibrils compared with the opposite orientation, a preference that flipped with the opposite monomer chirality. Furthermore, ATR-FTIR detected structural variations in the fibril structure, depending on the substrate magnetization. These findings suggest that transient spin polarization of the monomers during self-assembly, potentially driven by the Chiral-Induced Spin Selectivity (CISS) effect, plays a critical role in amyloid assembly dynamics. The consistency of these effects across different molecule length scales suggests a fundamental spin-based influence on biomolecular aggregation. This insight may have implications for therapeutic strategies, including the use of spin-polarized magnetic nanoparticles to selectively modulate amyloid formation in neurodegenerative diseases and the integration of spin-selective interfaces in dialysis systems to mitigate dialysis-related amyloidosis.
- Open Access
- 23 September 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2400575
EspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPases*
Enteropathogenic E. coli (EPEC) is a Gram-negative bacterial pathogen that causes persistent diarrhea. Upon attachment to the apical plasma membrane of the intestinal epithelium, the pathogen translocates virulence proteins called effectors into the infected cells. These effectors hijack numerous host processes for the pathogen's benefit. Therefore, studying the mechanisms underlying their action is crucial for a better understanding of the disease. We show that translocated EspH interacts with multiple host Rab GTPases. AlphaFold predictions and site-directed mutagenesis identified glutamic acid and lysine at positions 37 and 41 as Rab interacting residues in EspH. Mutating these sites abolished the ability of EspH to inhibit Akt and mTORC1 signaling, lysosomal exocytosis, and bacterial invasion. Knocking out the endogenous Rab8a gene expression highlighted the involvement of Rab8a in Akt/mTORC1 signaling and lysosomal exocytosis. A phosphoinositide binding domain with a critical tyrosine was identified in EspH. Mutating the tyrosine abolished the localization of EspH at infection sites and its capacity to interact with the Rabs. Our data suggest novel EspH-dependent mechanisms that elicit immune signaling and membrane trafficking during EPEC infection.
- 23 September 2024
- Published by Taylor & Francis in Gut Microbes
- Vol. 16 (1) , 2400575
Open AccessEspH utilizes phosphoinositide and Rab binding domains to interact with plasma membrane infection sites and Rab GTPases*
Enteropathogenic E. coli (EPEC) is a Gram-negative bacterial pathogen that causes persistent diarrhea. Upon attachment to the apical plasma membrane of the intestinal epithelium, the pathogen translocates virulence proteins called effectors into the infected cells. These effectors hijack numerous host processes for the pathogen's benefit. Therefore, studying the mechanisms underlying their action is crucial for a better understanding of the disease. We show that translocated EspH interacts with multiple host Rab GTPases. AlphaFold predictions and site-directed mutagenesis identified glutamic acid and lysine at positions 37 and 41 as Rab interacting residues in EspH. Mutating these sites abolished the ability of EspH to inhibit Akt and mTORC1 signaling, lysosomal exocytosis, and bacterial invasion. Knocking out the endogenous Rab8a gene expression highlighted the involvement of Rab8a in Akt/mTORC1 signaling and lysosomal exocytosis. A phosphoinositide binding domain with a critical tyrosine was identified in EspH. Mutating the tyrosine abolished the localization of EspH at infection sites and its capacity to interact with the Rabs. Our data suggest novel EspH-dependent mechanisms that elicit immune signaling and membrane trafficking during EPEC infection.